Dogwood Therapeutics (DWTX) Earnings Date & Reports

Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

DWTX is expected to report earnings to fall 55.88% to -15 cents per share on November 05

Dogwood Therapeutics DWTX Stock Earnings Reports

Q3'26

Est.

$-0.15

Q2'26

Missed

by $0.20

Q1'26

Beat

by $0.47

Q4'25

Missed

by $0.20

Q3'25

Missed

by $8.15

The last earnings report on August 13 showed earnings per share of -34 cents, missing the estimate of -13 cents. With 37.92K shares outstanding, the current market capitalization sits at 46.23M.

View a ticker or compare two or three

DWTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for DWTX